Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

被引:534
作者
Loeffler, Dennis
Brocke-Heidrich, Katja
Pfeifer, Gabriele
Stocsits, Claudia
Hackermueller, Joerg
Kretzschmar, Antje K.
Burger, Renate
Gramatzki, Martin
Blumert, Conny
Bauer, Kay
Cvijic, Helena
Ullmann, A. Kerstin
Stadler, Peter F.
Horn, Friedemann [1 ]
机构
[1] Univ Leipzig, Fac Med, Inst Clin Immunol & Transfus Med, Leipzig, Germany
[2] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany
[3] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany
[4] Univ Hosp Schleswig, Dept Med 2, Div Stem Cell Transplantat & Immunotherapy, Kiel, Germany
[5] Univ Leipzig, Interdisciplinary Ctr Clin Studies, Leipzig, Germany
关键词
D O I
10.1182/blood-2007-03-081133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Signal transducer and activator of transcription 3 (Stat3) is implicated in the pathogenesis of many malignancies and essential for IL-6-dependent survival and growth of multiple myeloma cells. Here, we demonstrate that the gene encoding oncogenic microRNA-21 (miR-21) is controlled by an upstream enhancer containing 2 Stat:3 binding sites strictly conserved since the first observed evolutionary appearance of miR-21 and Stat3. MiR-21 induction by IL-6 was strictly Stat3 dependent. Ectopically raising miR-21 expression in myeloma cells in the absence of IL-6 significantly reduced their apoptosis levels. These data provide strong evidence that miR-21 induction contributes to the oncogenic potential of Stat3.
引用
收藏
页码:1330 / 1333
页数:4
相关论文
共 25 条
[1]   Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma [J].
Aoki, Y ;
Feldman, GM ;
Tosato, G .
BLOOD, 2003, 101 (04) :1535-1542
[2]   BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription [J].
Brocke-Heidrich, K. ;
Ge, B. ;
Cvijic, H. ;
Pfeifer, G. ;
Loeffler, D. ;
Henze, C. ;
McKeithan, T. W. ;
Horn, F. .
ONCOGENE, 2006, 25 (55) :7297-7304
[3]   Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation [J].
Brocke-Heidrich, K ;
Kretzschmar, AK ;
Pfeifer, G ;
Henze, C ;
Löffler, D ;
Koczan, D ;
Thiesen, HJ ;
Burger, R ;
Gramatzki, M ;
Horn, F .
BLOOD, 2004, 103 (01) :242-251
[4]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[5]   Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs [J].
Cai, XZ ;
Hagedorn, CH ;
Cullen, BR .
RNA, 2004, 10 (12) :1957-1966
[6]   MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J].
Chan, JA ;
Krichevsky, AM ;
Kosik, KS .
CANCER RESEARCH, 2005, 65 (14) :6029-6033
[7]   Real-time quantification of microRNAs by stem-loop RT-PCR [J].
Chen, CF ;
Ridzon, DA ;
Broomer, AJ ;
Zhou, ZH ;
Lee, DH ;
Nguyen, JT ;
Barbisin, M ;
Xu, NL ;
Mahuvakar, VR ;
Andersen, MR ;
Lao, KQ ;
Livak, KJ ;
Guegler, KJ .
NUCLEIC ACIDS RESEARCH, 2005, 33 (20) :e179.1-e179.9
[8]   MicroRNAs modulate hematopoietic lineage differentiation [J].
Chen, CZ ;
Li, L ;
Lodish, HF ;
Bartel, DP .
SCIENCE, 2004, 303 (5654) :83-86
[9]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[10]   Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer [J].
Haura, EB ;
Turkson, J ;
Jove, R .
NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06) :315-324